Product Information
MESALAMINE 800 MG DR TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $4.3205 per EA under NDC 68382043528. Its NADAC has been published 399 times since Nov 7, 2018.
Strength
800 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382043528
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MESALAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA203286On Market Since
8/2/2018
Pharmacological Classes
Price Statistics
The NADAC for MESALAMINE 800 MG DR TABLET has been published 399 times since Nov 7, 2018, and over the history we have for it it has declined 17.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.3205 per EA |
|---|---|
| All-time high | $6.6478 (Sep 11, 2019) |
| All-time low | $4.2583 (Apr 22, 2026) |
| 52-week high | $4.7363 |
| 52-week low | $4.2583 |
| Median price | $5.8409 |
| Average price | $5.7151 |
| Largest weekly change | +20.6% (Jul 19, 2023) |
| Weeks tracked | 399 |
| Tracking since | Nov 7, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the mesalamine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MESALAMINE 800 MG DR TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE 800 MG DR TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $4.3205 per EA (NDC 68382043528), effective Jun 24, 2026.
How has the price of MESALAMINE 800 MG DR TABLET changed over time?
Over the history we have for it, the NADAC for MESALAMINE 800 MG DR TABLET has declined 17.4%. It has been tracked across 399 weekly CMS publications since Nov 7, 2018.
What are the highest and lowest recorded NADAC prices for MESALAMINE 800 MG DR TABLET?
Since Nov 7, 2018, the NADAC for MESALAMINE 800 MG DR TABLET has ranged from a low of $4.2583 (Apr 22, 2026) to a high of $6.6478 (Sep 11, 2019), with a median of $5.8409 per EA.
Are there cheaper alternatives to MESALAMINE 800 MG DR TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MESALAMINE 800 MG DR TABLET, so no direct lower-cost alternative is listed.
Who manufactures MESALAMINE 800 MG DR TABLET?
MESALAMINE 800 MG DR TABLET (NDC 68382043528) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification